Niki BioSolutions (NIKI) vs XCHG (XCH)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Niki BioSolutions (NIKI) has outperformed XCHG (XCH) over the past year, losing 83.1% versus a loss of 87.5%. Niki BioSolutions is the larger company by market cap ($12.5 million vs $11.8 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | NIKI | XCH |
|---|---|---|
| Share price | $4.00 | $2.94 |
| Market cap | $12.47M | $11.76M |
| 1-day change | -7.41% | -1.67% |
| YTD return | -62.26% | -86.77% |
| 1-year return | -83.12% | -87.54% |
| 5-year return | -98.46% | — |
| EPS (TTM) | $-2.90 | $-8.80 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $17.60 | $49.98 |
| 52-week low | $4.00 | $2.55 |
| Distance from 52-week high | -77.27% | -94.12% |
| Average volume | 160.00K | 41.39K |
| Shares outstanding | 2.94M | 3.07M |
| Employees | 1 | 177 |
| Sector | Industrials | Miscellaneous |
| Industry | Industrial Machinery/Components | Industrial Machinery/Components |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- The two companies sit in different sectors: Niki BioSolutions in Industrials and XCHG in Miscellaneous.
About Niki BioSolutions
NIKI stock →Niki BioSolutions, Inc., through its subsidiaries, operates as a clinical-stage biopharmaceutical company and engages in the discovery, development, and commercialization of therapeutic products to treat oncology and infectious diseases. Its pipeline products include SACT-1, a repurposed drug candidate, which is in a Phase 1 clinical trial to treat neuroblastoma and other cancer types; ALS-4, a repurposed small molecule, which is in a Phase 1 clinical trial for the treatment of bacterial infections, such as staphylococcus aureus, mycobacterium tuberculosis, and pseudomonas aeruginosa.
Industrials · Industrial Machinery/Components · 1 employees
About XCHG
XCH stock →XCHG Limited, together with its subsidiaries, engages in designing, manufacturing, and selling of electric vehicle (EV) chargers under the X-Charge brand name in Europe, the People's Republic of China, the United States, and internationally. The company offers direct current (DC) fast chargers under the C6 series and C7 series; and battery-integrated DC fast chargers under the Net Zero series and GridLink, as well as software system upgrades and hardware maintenance services.
Miscellaneous · Industrial Machinery/Components · 177 employees
NIKI vs XCH FAQ
Which is bigger, Niki BioSolutions or XCHG?
Niki BioSolutions (NIKI) is larger, with a market capitalization of $12.47M compared with $11.76M for XCHG (XCH).
Which stock has performed better over the past year, NIKI or XCH?
NIKI returned -83.12% over the past 12 months, compared with -87.54% for XCH (price return, excluding dividends). Past performance does not predict future results.
Are Niki BioSolutions and XCHG in the same industry?
Yes. Both are classified in the Industrial Machinery/Components industry within the Industrials sector.